NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
17478-542-02 | 17478-542 | HUMAN PRESCRIPTION DRUG | Adenosine | Adenosine | INJECTION, SOLUTION | INTRAVENOUS | 20110315 | 20241130 | ANDA | ANDA078076 | Akorn | ADENOSINE | 3 mg/mL | 10 VIAL in 1 CARTON (17478-542-02) / 2 mL in 1 VIAL |
17478-542-25 | 17478-542 | HUMAN PRESCRIPTION DRUG | Adenosine | Adenosine | INJECTION, SOLUTION | INTRAVENOUS | 20110315 | 20241130 | ANDA | ANDA078076 | Akorn | ADENOSINE | 3 mg/mL | 25 VIAL in 1 CARTON (17478-542-25) / 2 mL in 1 VIAL |
51662-1201-1 | 51662-1201 | HUMAN PRESCRIPTION DRUG | Adenosine Injection, 6mg/2mL (3mg/mL) Vial | Adenosine Injection, 6mg/2mL (3mg/mL) Vial | INJECTION, SOLUTION | INTRAVENOUS | 20180714 | N/A | ANDA | ANDA078076 | HF Acquisition Co. LLC, DBA Health First | ADENOSINE | 3 mg/mL | 2 mL in 1 VIAL (51662-1201-1) |
0404-9809-02 | 0404-9809 | HUMAN PRESCRIPTION DRUG | Adenosine | Adenosine | INJECTION, SOLUTION | INTRAVENOUS | 20220106 | 20241130 | ANDA | ANDA078076 | Henry Schein, Inc. | ADENOSINE | 3 mg/mL | 1 VIAL in 1 BAG (0404-9809-02) / 2 mL in 1 VIAL |